HEADER HORMONE 24-MAR-17 5NIQ TITLE EXENDIN-4 VARIANT WITH DUAL GLP-1 / GLUCAGON RECEPTOR ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXENDIN-4; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELODERMA SUSPECTUM; SOURCE 4 ORGANISM_COMMON: GILA MONSTER; SOURCE 5 ORGANISM_TAXID: 8554 KEYWDS EXENDIN-4 ANALOGUE, DUAL GLP-1 / GLUCAGON AGONIST, HORMONE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.EVERS,M.KURZ REVDAT 5 14-JUN-23 5NIQ 1 REMARK REVDAT 4 11-SEP-19 5NIQ 1 REMARK HELIX LINK SITE REVDAT 4 2 1 ATOM REVDAT 3 08-MAY-19 5NIQ 1 REMARK REVDAT 2 27-MAR-19 5NIQ 1 JRNL REVDAT 1 28-FEB-18 5NIQ 0 JRNL AUTH A.EVERS,T.HAACK,M.LORENZ,M.BOSSART,R.ELVERT,B.HENKEL, JRNL AUTH 2 S.STENGELIN,M.KURZ,M.GLIEN,A.DUDDA,K.LORENZ,D.KADEREIT, JRNL AUTH 3 M.WAGNER JRNL TITL DESIGN OF NOVEL EXENDIN-BASED DUAL GLUCAGON-LIKE PEPTIDE 1 JRNL TITL 2 (GLP-1)/GLUCAGON RECEPTOR AGONISTS. JRNL REF J.MED.CHEM. V. 60 4293 2017 JRNL REFN ISSN 0022-2623 JRNL PMID 28448133 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00174 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SYBYL 2.1.1 REMARK 3 AUTHORS : TRIPOS REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NIQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200003326. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : 35MM SODIUM PHOSPHATE REMARK 210 PRESSURE : 1 PA REMARK 210 SAMPLE CONTENTS : 5 MG/ML PEPTID 14, REMARK 210 TRIFLUOROETHANOL/WATER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : 1; 2 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, CARA RELEASE: REMARK 210 1.8.4.2 REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 9 HZ3 LYS A 12 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 ARG A 18 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 1 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.0 DEGREES REMARK 500 2 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 3 ARG A 17 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 3 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.0 DEGREES REMARK 500 4 ARG A 18 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 4 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 5 ARG A 17 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 5 ARG A 18 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 5 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 6 ARG A 18 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 6 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 8 ARG A 18 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 8 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -4.9 DEGREES REMARK 500 9 ARG A 17 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 9 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 10 TRP A 25 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 3 172.89 62.36 REMARK 500 2 THR A 5 39.90 38.71 REMARK 500 4 THR A 5 26.97 48.31 REMARK 500 6 GLN A 3 98.99 66.04 REMARK 500 7 THR A 5 -57.81 70.08 REMARK 500 7 PHE A 6 -62.68 65.25 REMARK 500 8 DSN A 2 169.96 75.61 REMARK 500 8 GLN A 3 -65.97 65.65 REMARK 500 8 PHE A 6 -62.10 65.45 REMARK 500 8 PRO A 38 91.93 -68.37 REMARK 500 9 GLN A 3 -69.48 65.86 REMARK 500 9 PHE A 6 -51.58 87.73 REMARK 500 9 PRO A 38 88.27 -50.73 REMARK 500 10 THR A 5 39.90 38.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue D6M A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand NH2 A 40 bound to SER A REMARK 800 39 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34119 RELATED DB: BMRB REMARK 900 EXENDIN-4 VARIANT WITH DUAL GLP-1 / GLUCAGON RECEPTOR ACTIVITY DBREF 5NIQ A 1 39 PDB 5NIQ 5NIQ 1 39 SEQRES 1 A 40 HIS DSN GLN GLY THR PHE THR SER ASP LEU SER LYS GLN SEQRES 2 A 40 LYS ASP SER ARG ARG ALA GLN ASP PHE ILE GLU TRP LEU SEQRES 3 A 40 LYS ASN GLY GLY PRO SER SER GLY ALA PRO PRO PRO SER SEQRES 4 A 40 NH2 HET DSN A 2 11 HET NH2 A 40 3 HET D6M A 101 63 HETNAM DSN D-SERINE HETNAM NH2 AMINO GROUP HETNAM D6M N-HEXADECANOYL-L-GLUTAMIC ACID FORMUL 1 DSN C3 H7 N O3 FORMUL 1 NH2 H2 N FORMUL 2 D6M C21 H39 N O5 HELIX 1 AA1 THR A 5 GLY A 29 1 25 HELIX 2 AA2 GLY A 30 GLY A 34 5 5 LINK C HIS A 1 N DSN A 2 1555 1555 1.35 LINK C DSN A 2 N GLN A 3 1555 1555 1.36 LINK NZ LYS A 14 C07 D6M A 101 1555 1555 1.36 LINK C SER A 39 N NH2 A 40 1555 1555 1.35 SITE 1 AC1 3 LYS A 14 ARG A 17 ARG A 18 SITE 1 AC2 1 SER A 39 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1